
    
      This is a multicenter, randomized, double-blinded study. The efficacy with E3810 20 mg once
      daily is compared with E3810 20 mg twice daily and 10 mg twice daily using endoscopic
      recovery. The frequency of adverse event, etc., will be compared among 3 groups for safety
      assessment.
    
  